Results 121 to 130 of about 22,526 (176)

CXC Chemokine-Driven Vascular Reprogramming: Modulating Tumor Vasculature to Boost Therapeutic Response. [PDF]

Adv Sci (Weinh)
Chen H, Huang Y, Wu J, Yi Z, Li Y, Yang Z, Zhang F, Li C.   +7 more
europepmc   +1 more source

Long-term polystyrene nanoplastics exposure aggravates retinal inflammation and photoreceptor degeneration through microglial SPP1 signaling and neutrophil extracellular traps formation. [PDF]

J Transl Med
Zhou W, Chen X, Li J, He J.
europepmc   +1 more source

Mechanisms and biomarkers of immune checkpoint inhibitor-associated myocarditis: from T cell imbalance to multicellular crosstalk. [PDF]

Front Immunol
Huang J, Xu X, Jin Y, Qiao L, Yu H, Gao W, Li C.   +6 more
europepmc   +1 more source

Macrophage-derived chemokines in T cell regulation: implications for cancer immunotherapy. [PDF]

Front Immunol
Zhang K, Liu J, Liu Q, Zhu N, Ye B.
europepmc   +1 more source

Tumor-targeted aptamer-conjugated engineered bacteria for CXCL9 cytokine delivery in non-small cell lung cancer immunotherapy. [PDF]

J Transl Med
Gu Q, Wang R, Zhang L, Pan D, Bian C, Jia E, Chang J, Zhang H.   +7 more
europepmc   +1 more source

Chemokine-chemokine receptor axis: Emerging immunotherapeutic paradigms for solid tumor microenvironment reprogramming. [PDF]

Chin Med J (Engl)
Zhao Y, Wang X, Lei T, Lu H, Zhao Y, Wang G.   +5 more
europepmc   +1 more source

Single-cell transcriptomic insights into the immune heterogeneity of immune checkpoint inhibitors related organ toxicities. [PDF]

Front Immunol
Wen H, Qi Y, Song J, Yan X.
europepmc   +1 more source

Chemokines and chemokine receptors in metabolic dysfunction-associated steatohepatitis: pathogenic mechanisms and clinical implications. [PDF]

Cell Mol Biol Lett
Yin M, Zhang Y, Liu S, Li X.
europepmc   +1 more source

IER3 as an RFX5 transcriptional co-activator promotes hepatocellular carcinoma progression via AKR1B10-mediated p53 transcriptional regulation. [PDF]

Discov Oncol
Chen X, Zhang Q, Zhang N.
europepmc   +1 more source

Divergent roles of serum CXCL9 as a biomarker in ILD and COPD: a comparative study. [PDF]

Front Pharmacol
Yin C, Kang X, Zhang Y, Song J, Hasegawa T, Yao L, Hu Y, Li H.   +7 more
europepmc   +1 more source